Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Controlled Release Drug Delivery Market Growth in 2025?

In recent years, the market size for controlled release drug delivery has expanded swiftly. It is forecasted to rise from $65.44 billion in 2024 to $73.01 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. The growth experienced in the historical period is linked to the amendment and advancement in drug delivery systems, the inception of early polymer-based formulations, the development and implementation of microencapsulation techniques, the transformation brought about by transdermal delivery, the acquisition of regulatory approvals, and the achievement of standardization.

What Is the Forecast for the Controlled Release Drug Delivery Market Size Through 2029?

In the coming years, the market size for controlled release drug delivery is projected to experience significant expansion, reaching a worth of $119.41 billion by 2029, with a compound annual growth rate (CAGR) of 13.1%. The forecasted growth during this period is because of several factors, such as the transition to personalized medicine, the incorporation of technology for patient ease, the growth of biologics and biosimilars, market growth in emerging regions, and progress in polymer science. Key trends to watch during the forecast period encompass biodegradable and biocompatible materials, the progress of nanotechnology, personalized and targeted medicine therapies, upgrades in implantable devices, and pioneering encapsulation methods.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp

What are the Key Market Players in Controlled Release Drug Delivery Market and How They’re Evolving?

Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

What Are the Primary Growth Drivers in the Controlled Release Drug Delivery Market?

The increasing instances of chronic diseases are anticipated to drive the growth of the controlled release drug delivery market. These chronic conditions, also referred to as noncommunicable diseases, include ailments like heart disease, cancer, and diabetes that usually last more than a year, necessitate ongoing medical care, and may limit daily activities. The use of controlled-release drug delivery systems plays a vital role in chronic disease treatment. For chronic patients needing long-term treatment or those living in areas with limited healthcare resources and access, drug delivery systems that facilitate extended medication release are crucial. For example, the World Health Organization (WHO), a health-specialized agency based in Switzerland, reported in September 2022 that chronic diseases cause 41 million deaths annually, constituting 74 percent of all deaths worldwide. Chronic diseases result in the premature death of 17 million individuals before they reach 70 years of age, and 77 percent of these deaths occur in low- and middle-income countries. These numbers are predicted to increase in the future. Hence, the surging instances of chronic diseases are driving the expansion of the controlled release drug delivery market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9930&type=smp

What Are the Leading Segments in the Global Controlled Release Drug Delivery Industry?

The controlled release drug delivery market covered in this report is segmented –

1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies

2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,

3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications

4) By End User: Hospitals, Clinics, Personal, Research, Other End Users

Subsegments:

1) By Wurster Technique: Spray Coating, Fluid Bed Coating

2) By Coacervation: Simple Coacervation, Complex Coacervation

3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation

4) By Implants: Biodegradable Implants, Non-Biodegradable Implants

5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems

6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes

7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems

What Are the Key Market Trends in the Controlled Release Drug Delivery Industry?

The rise of technological innovation is an emerging trend in the controlled-release drug delivery market. Major firms in this sector are embracing cutting-edge technologies to maintain market dominance. An example is Evonik Industries AG, a pharmaceutical company based in Germany, which launched UDRATEC SoluFlow in March 2022. This innovative microparticle technology has been developed to enhance the solubility of active ingredients in oral drug formulations. Unlike conventional production techniques, this emulsion-based process can overcome solidity challenges. EUDRATEC SoluFlow is part of Evonik Health Care’s portfolio of oral drug delivery systems, which feature oral excipients like EUDRAGIT functional polymers, ready-to-fill capsules such as EUDRACAPTM, and multiple other techniques and services to augment drug performance.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

What Is the Regional Outlook for the Controlled Release Drug Delivery Market?

North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9930

This Report Delivers Insight On:

1. How big is the controlled release drug delivery market, and how is it changing globally?

2. Who are the major companies in the controlled release drug delivery market, and how are they performing?

3. What are the key opportunities and risks in the controlled release drug delivery market right now?

4. Which products or customer segments are growing the most in the controlled release drug delivery market?

5. What factors are helping or slowing down the growth of the controlled release drug delivery market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model